Clinical trial Recruiting at 1 site Interventional Ages 18 to 35

Assessing corneal health after lens implantation

Official title: Corneal Endothelial Assessment After Posterior Chamber Phakic Intraocular Lens Implantation

Run by Sohag University · NCT06849375 · Data updated 2026-11-12

This study tests how putting a special lens in the eye affects the health of the cornea in young adults over time.

More Fuchs Endothelial Corneal Dystrophy trials

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexAll
Enrollment30 (estimated)
SponsorSohag University
Academic / other
Locations1 site (Sohag, Sohag Governorate)
StatusRecruiting
StartedMay 10, 2024
Main results expectedDecember 20, 2025
Study endsDecember 20, 2025
Registry record updatedFebruary 27, 2025
Trial IDNCT06849375 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-35 with high myopia and sufficient anterior chamber depth.

Probably not a fit

Patients with previous eye diseases, surgeries, or insufficient anterior chamber depth may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact of phakic intraocular lens (IOL) implantation on the corneal endothelium in young adults. Using a specular microscope, researchers will measure changes in corneal endothelial cell density following the procedure. The study aims to determine whether this type of lens implantation affects corneal health over time. Participants will be monitored for endothelial cell counts to assess any potential adverse effects.

Why it matters

Potential benefit: If successful, this study could provide insights into the safety of phakic IOLs and their long-term effects on corneal health.

How similar studies have gone: While similar studies have been conducted, the specific focus on corneal endothelial assessment post-phakic IOL implantation may provide novel insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Our inclusion criteria include: adults 18-35 years of age, myopia ˃ 6 D , anterior chamber depth (ACD) 2.85 mm or greater , an endothelial cell count of ≥ 2000 cells/mm2 and stable refractive history within 0.5 diopter for 1 year.

Exclusion Criteria:

* anterior chamber depth from endothelium \< 2.85 mm, previous or current systemic or eye disease , surgery or trauma, pregnancy and nursing.

Where it's running

  • Sohag University Hospital
    Sohag, Sohag Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.